SCP
ABBV icon

Silverleafe Capital Partners’s AbbVie ABBV Stock Holding History

Silverleafe Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$509K Sell
1,945
-339
-15% -$86.9K 0.14% 65
2026
Q2 		$575K Buy
2,284
+2
+0.1% +$430 0.16% 58
2026
Q1 		$496K Buy
2,282
+1
+0% +$222 0.15% 61
2025
Q4 		$521K Buy
2,281
+1
+0% +$228 0.15% 61
2025
Q3 		$528K Buy
2,280
+44
+2% +$8.96K 0.16% 53
2025
Q2 		$415K Buy
2,236
+88
+4% +$16.4K 0.14% 54
2025
Q1 		$450K Buy
2,148
+56
+3% +$10.9K 0.15% 55
2024
Q4 		$372K Hold
2,092
– – 0.12% 79
2024
Q3 		$413K Buy
2,092
+2
+0.1% +$373 0.14% 59
2024
Q2 		$358K Hold
2,090
– – 0.12% 58
2024
Q1 		$381K Hold
2,090
– – 0.15% 50
2023
Q4 		$324K Hold
2,090
– – 0.15% 39
2023
Q3 		$312K Hold
2,090
– – 0.16% 39
2023
Q2 		$282K Hold
2,090
– – 0.17% 42
2023
Q1 		$333K Buy
2,090
+17
+0.8% +$2.6K 0.21% 40
2022
Q4 		$335K Hold
2,073
– – 0.22% 40
2022
Q3 		$278K Hold
2,073
– – 0.18% 51
2022
Q2 		$318K Hold
2,073
– – 0.19% 43
2022
Q1 		$336K Hold
2,073
– – 0.15% 51
2021
Q4 		$281K Hold
2,073
– – 0.1% 74
2021
Q3 		$224K Sell
2,073
-12
-0.6% -$1.37K 0.09% 75
2021
Q2 		$235K Hold
2,085
– – 0.09% 78
2021
Q1 		$226K Buy
2,085
+12
+0.6% +$1.28K 0.09% 82
2020
Q4 		$222K Buy
+2,073
New +$199K 0.1% 69
2020
Q3 		– Sell
-17,430
Closed -$1.71M – 65
2020
Q2 		$1.71M Buy
17,430
+13,583
+353% +$1.2M 1.17% 25
2020
Q1 		$293K Buy
3,847
+134
+4% +$11.4K 0.35% 30
2019
Q4 		$329K Buy
+3,713
New +$308K 0.19% 56

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Silverleafe Capital Partners's ABBV Position: Q3 2026 in Review

Silverleafe Capital Partners reduced its AbbVie (ABBV) stake by 15% in Q3 2026, selling an estimated $86.9K and leaving 1,945 shares worth $509K. The position accounts for 0.14% of the portfolio, ranked #65.

Silverleafe Capital Partners first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.71M in Q2 2020. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Silverleafe Capital Partners held 1,945 shares of AbbVie worth $509K as of Q3 2026.
  • Silverleafe Capital Partners sold 339 AbbVie shares in Q3 2026, an estimated $86.9K.
  • AbbVie made up 0.14% of Silverleafe Capital Partners's portfolio in Q3 2026, its #65 holding.
  • Silverleafe Capital Partners first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Silverleafe Capital Partners's AbbVie position peaked at $1.71M in Q2 2020.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Silverleafe Capital Partners's 13F filing for Q3 2026, filed 2 Oct 2026.